We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Clears Novartis-Hexal Deal Pending Product Sales
EU Clears Novartis-Hexal Deal Pending Product Sales
June 3, 2005
Novartis has agreed to sell products in three European countries to gain final European Union (EU) approval for its planned merger of German generic drugmaker Hexal AG and Hexal’s U.S. sister company Eon Labs, the European Commission (EC) announced May 27.